Form D · Other Health Care
Abrexa Pharmaceuticals, Inc.
San Diego, CA · CIK 0001529349
Offering snapshot reported Apr 28, 2025 · SEC filing
- Reported sold
- $23M Offering amount: $23M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 28, 2025 | Initial | $22,999,999 | No comparison | 2 | SEC filing |
| Feb 7, 2019 | Amendment | $16,632,252 | $9,000,000vs Aug 8, 2018 | 7 | SEC filing |
| Aug 8, 2018 | Initial | $7,632,252 | No comparison | 7 | SEC filing |
| Sep 6, 2011 | Initial | $500,793 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-544571
Source: Form D, filed Apr 28, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Hughley | Director |
| David Hugley | Director |
| Lynne Rollins | Executive |
| James J. Truchard | Director |
| J. Ernest Villafranca | Director, Executive |
| Nicole Vitullo | Director |
| Eckard Weber, M.D. | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
402 W Broadway Suite 400
San Diego, CA, 92101
San Diego, CA, 92101